Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
IOmx logo — iOmx Therapeutics develops cancer treatments targeting immun...

IOmx

iOmx Therapeutics develops cancer treatments targeting immune checkpoint modulators on tumor cells. Targets identified through systematic screening.

Founded 2016 Germany Planegg, Germany 11-50 employees Pharmaceutical

General Information

Company Name IOmx
Founded Year 2016
Location Germany Planegg, Germany
Employees 11-50
Industries Pharmaceutical
Social

Get notified when IOmx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IOmx

Therapeutics, a German pharmaceutical startup founded in 2016, is dedicated to developing innovative cancer treatments. The company's slogan, "iOmx Therapeutics develops cancer treatments targeting immune checkpoint modulators on tumor cells. Targets identified through systematic screening.", highlights its focus on targeting immune checkpoint modulators present on tumor cells. Through meticulous screening of human tumor cells, has identified several cutting-edge targets within the pharmaceutical industry and thoroughly analyzed their mechanisms of action. With a focus on targeting newly-discovered immune checkpoint modulators, the company shows promise in the advancement of cancer treatment. As of now, there is no public information available regarding the last investment or the investors involved.

Taxonomy: Cancer treatments, Immune checkpoint modulators, Tumor cells, Innovative treatments, Target identification, Screening, Cutting-edge targets, Mechanism of action analysis, Immuno-oncology, Drug development, Therapeutics, Precision medicine

No funding data available for IOmx yet.

Get notified when IOmx raises funding

IOmx Alternatives & Competitors

IOmx vs
Duet BioTherapeutics
Duet BioTherapeutics United States

A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cancers.

Series Unknown
2 employees
Biopharma, Biotechnology
IOmx vs
Riboscience
Riboscience United States

Riboscience is a biotechnology company developing treatments for serious infectious diseases and can...

16 employees
Biotechnology, Information Technology
IOmx vs
AgonOx, Inc.
AgonOx, Inc.

DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER...

5 employees
Biotechnology, Pharmaceutical

FAQ About IOmx

iOmx Therapeutics develops cancer treatments targeting immune checkpoint modulators on tumor cells. Targets identified through systematic screening.
IOmx was founded in 2016.
IOmx is headquartered in Planegg, Germany.
IOmx operates in the following industries: Pharmaceutical.
IOmx has approximately 11-50 employees.
Top alternatives and competitors to IOmx include Duet BioTherapeutics, Riboscience, AgonOx, Inc., Buzzard Pharmaceuticals, Intensity Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IOmx and Duet BioTherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IOmx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy